Histologically and genetically identical to conventional deep LGFMS
Clinical Issues
•
Appear to represent 10-20% of reported cases of LGFMS
•
Often adults (typically 3rd-4th decade), but wide range
Up to 1/3 arise in children and adolescents
•
Most common in extremities (especially lower limb), buttock, and trunk
•
Treatment: Complete surgical excision
•
Better outcome reported than in deep forms of LGFMS
•
Local recurrence uncommon; no metastases reported
Macroscopic
•
Well-defined mass, most often in subcutis
•
Median 4.2 cm (occasionally > 10 cm)
Microscopic
•
Identical cytomorphologic features and spectrum as conventional LGFMS
•
Variant morphology includes component of distinct collagen rosette-like structures
Ancillary Tests
•
Diffuse MUC4(+) characteristic
•
Rare focal or weak expression of CD34, EMA, or claudin-1
•
Negative for keratins, S100, SMA, desmin
•
Molecular:
FUS rearrangements with
CREB3L2 or
CREB3L1
Top Differential Diagnoses
•
Dermatofibrosarcoma protuberans
TERMINOLOGY
Abbreviations
•
Low-grade fibromyxoid sarcoma (LGFMS)
Synonyms
•
Hyalinizing spindle cell tumor with giant rosettes
•
Fibrosarcoma, fibromyxoid type
Definitions
•
Subset of low-grade fibromyxoid sarcoma arising in dermis &/or subcutaneous tissue
Histologically and genetically identical to conventional deep LGFMS
CLINICAL ISSUES
Epidemiology
•
Incidence
Appear to represent 10-20% of reported cases of LGFMS
Probably underreported in literature
•
Age
Often adults (typically 3rd-4th decade) but wide range
–
Up to 1/3 arise in children and adolescents
•
Sex
M > F
Site
•
Most common in extremities (especially lower limb), buttock, and trunk
•
Occasionally other sites
Presentation
•
Usually slow-growing, painless mass